Year |
Citation |
Score |
2023 |
Pradhan L, Moore D, Ovadia EM, Swedzinski SL, Cossette T, Sikes RA, van Golen K, Kloxin AM. Dynamic bioinspired coculture model for probing ER breast cancer dormancy in the bone marrow niche. Science Advances. 9: eade3186. PMID 36888709 DOI: 10.1126/sciadv.ade3186 |
0.543 |
|
2022 |
Rypens C, Bertucci F, Finetti P, Robertson F, Fernandez SV, Ueno N, Woodward WA, Van Golen K, Vermeulen P, Dirix L, Viens P, Birnbaum D, Devi GR, Cristofanilli M, Van Laere S. Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC. Npj Breast Cancer. 8: 12. PMID 35042871 DOI: 10.1038/s41523-021-00379-6 |
0.384 |
|
2020 |
Ovadia EM, Pradhan L, Sawicki LA, Cowart JE, Huber RE, Polson SW, Chen C, van Golen KL, Ross KE, Wu CH, Kloxin AM. Understanding ER+ Breast Cancer Dormancy Using Bioinspired Synthetic Matrices for Long-Term 3D Culture and Insights into Late Recurrence. Advanced Biosystems. e2000119. PMID 32603024 DOI: 10.1002/adbi.202000119 |
0.537 |
|
2017 |
Woodward WA, Cristofanilli M, Merajver SD, Van Laere S, Pusztai L, Bertucci F, Berditchevski F, Polyak K, Overmoyer B, Devi GR, Sterneck E, Schneider R, Debeb BG, Wang X, van Golen KL, et al. Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10 Anniversary Conference. Journal of Cancer. 8: 3607-3614. PMID 29667990 DOI: 10.7150/Jca.21200 |
0.339 |
|
2017 |
Joglekar-Javadekar M, Van Laere S, Bourne M, Moalwi M, Finetti P, Vermeulen PB, Birnbaum D, Dirix LY, Ueno N, Carter M, Rains J, Ramachandran A, Bertucci F, van Golen KL. Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC). Neoplasia (New York, N.Y.). 19: 564-573. PMID 28609680 DOI: 10.1016/J.Neo.2017.03.002 |
0.603 |
|
2017 |
Joglekar M, Elbazanti WO, Weitzman MD, Lehman HL, van Golen KL. Caveolin-1 Mediates Inflammatory Breast Cancer Cell Invasion via the Akt1 Pathway and RhoC GTPase. Journal of Cellular Biochemistry. 118: 1273. PMID 28316145 DOI: 10.1002/Jcb.25876 |
0.814 |
|
2015 |
Joglekar M, Elbazanti WO, Weitzman MD, Lehman HL, van Golen KL. Caveolin-1 mediates inflammatory breast cancer cell invasion via the Akt1 pathway and RhoC GTPase. Journal of Cellular Biochemistry. 116: 923-33. PMID 25559359 DOI: 10.1002/Jcb.25025 |
0.814 |
|
2013 |
van Golen KL, Cristofanilli M. The Third International Inflammatory Breast Cancer Conference. Breast Cancer Research : Bcr. 15: 318. PMID 24188125 DOI: 10.1186/bcr3571 |
0.573 |
|
2013 |
Lehman HL, Dashner EJ, Lucey M, Vermeulen P, Dirix L, Van Laere S, van Golen KL. Modeling and characterization of inflammatory breast cancer emboli grown in vitro. International Journal of Cancer. 132: 2283-94. PMID 23129218 DOI: 10.1002/Ijc.27928 |
0.678 |
|
2013 |
Schaefer RJ, Bonor JC, Joglekar MS, Van Golen KL, Nohe AG. 1, 25 Dihydroxyvitamin D3 uptake is localized at caveolae and requires caveolar function Journal of Biomedical Nanotechnology. 9: 1707-1715. DOI: 10.1166/jbn.2013.1662 |
0.396 |
|
2012 |
Martin BJ, van Golen KL. A comparison of cholesterol uptake and storage in inflammatory and noninflammatory breast cancer cells. International Journal of Breast Cancer. 2012: 412581. PMID 23346407 DOI: 10.1155/2012/412581 |
0.524 |
|
2012 |
Gurski LA, Xu X, Labrada LN, Nguyen NT, Xiao L, van Golen KL, Jia X, Farach-Carson MC. Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogels. Plos One. 7: e50075. PMID 23166824 DOI: 10.1371/Journal.Pone.0050075 |
0.39 |
|
2012 |
Lehman HL, Van Laere SJ, van Golen CM, Vermeulen PB, Dirix LY, van Golen KL. Regulation of inflammatory breast cancer cell invasion through Akt1/PKBα phosphorylation of RhoC GTPase. Molecular Cancer Research : McR. 10: 1306-18. PMID 22896661 DOI: 10.1158/1541-7786.Mcr-12-0173 |
0.805 |
|
2012 |
Hillyer RL, Sirinvasin P, Joglekar M, Sikes RA, van Golen KL, Nohe A. Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines. Clinical & Experimental Metastasis. 29: 971-9. PMID 22610818 DOI: 10.1007/S10585-012-9486-0 |
0.547 |
|
2011 |
Chaterjee M, van Golen KL. Breast cancer stem cells survive periods of farnesyl-transferase inhibitor-induced dormancy by undergoing autophagy. Bone Marrow Research. 2011: 362938. PMID 22046561 DOI: 10.1155/2011/362938 |
0.526 |
|
2011 |
Chatterjee M, Sequeira L, Jenkins-Kabaila M, Dubyk CW, Pathak S, van Golen KL. Individual rac GTPases mediate aspects of prostate cancer cell and bone marrow endothelial cell interactions. Journal of Signal Transduction. 2011: 541851. PMID 21776386 DOI: 10.1155/2011/541851 |
0.721 |
|
2011 |
Chatterjee M, van Golen KL. Farnesyl transferase inhibitor treatment of breast cancer cells leads to altered RhoA and RhoC GTPase activity and induces a dormant phenotype. International Journal of Cancer. Journal International Du Cancer. 129: 61-9. PMID 20824700 DOI: 10.1002/Ijc.25655 |
0.807 |
|
2010 |
Vermeulen PB, van Golen KL, Dirix LY. Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer: a review of the current knowledge. Cancer. 116: 2748-54. PMID 20503405 DOI: 10.1002/Cncr.25169 |
0.481 |
|
2008 |
Hall CL, Dubyk CW, Riesenberger TA, Shein D, Keller ET, van Golen KL. Type I collagen receptor (alpha2beta1) signaling promotes prostate cancer invasion through RhoC GTPase. Neoplasia (New York, N.Y.). 10: 797-803. PMID 18670640 DOI: 10.1593/Neo.08380 |
0.341 |
|
2008 |
van Golen KL, Ying C, Sequeira L, Dubyk CW, Reisenberger T, Chinnaiyan AM, Pienta KJ, Loberg RD. CCL2 induces prostate cancer transendothelial cell migration via activation of the small GTPase Rac. Journal of Cellular Biochemistry. 104: 1587-97. PMID 18646053 DOI: 10.1002/Jcb.21652 |
0.39 |
|
2008 |
Cooper CR, Graves B, Pruitt F, Chaib H, Lynch JE, Cox AK, Sequeria L, van Golen KL, Evans A, Czymmek K, Bullard RS, Donald CD, Sol-Church K, Gendernalik JD, Weksler B, et al. Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha. Journal of Cellular Biochemistry. 104: 2298-309. PMID 18561328 DOI: 10.1002/Jcb.21785 |
0.334 |
|
2008 |
Sequeira L, Dubyk CW, Riesenberger TA, Cooper CR, van Golen KL. Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis. Clinical & Experimental Metastasis. 25: 569-79. PMID 18461284 DOI: 10.1007/s10585-008-9173-3 |
0.458 |
|
2008 |
Miles FL, Pruitt FL, van Golen KL, Cooper CR. Stepping out of the flow: capillary extravasation in cancer metastasis. Clinical & Experimental Metastasis. 25: 305-24. PMID 17906932 DOI: 10.1007/S10585-007-9098-2 |
0.508 |
|
2006 |
van Golen KL. Is caveolin-1 a viable therapeutic target to reduce cancer metastasis? Expert Opinion On Therapeutic Targets. 10: 709-21. PMID 16981828 DOI: 10.1517/14728222.10.5.709 |
0.38 |
|
2006 |
Hall CL, Dai J, van Golen KL, Keller ET, Long MW. Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone. Cancer Research. 66: 8648-54. PMID 16951179 DOI: 10.1158/0008-5472.Can-06-1544 |
0.381 |
|
2006 |
Zhang L, Chenwei L, Mahmood R, van Golen K, Greenson J, Li G, D'Silva NJ, Li X, Burant CF, Logsdon CD, Simeone DM. Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer. Cancer Research. 66: 898-906. PMID 16424023 DOI: 10.1158/0008-5472.Can-05-3025 |
0.407 |
|
2006 |
Yao H, Dashner EJ, van Golen CM, van Golen KL. RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility. Oncogene. 25: 2285-96. PMID 16314838 DOI: 10.1038/sj.onc.1209260 |
0.685 |
|
2006 |
Van Laere SJ, Van den Eynden GG, Van der Auwera I, Vandenberghe M, van Dam P, Van Marck EA, van Golen KL, Vermeulen PB, Dirix LY. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling. Breast Cancer Research and Treatment. 95: 243-55. PMID 16261404 DOI: 10.1007/S10549-005-9015-9 |
0.464 |
|
2006 |
Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Research and Treatment. 95: 219-28. PMID 16244790 DOI: 10.1007/S10549-005-9002-1 |
0.624 |
|
2005 |
Radunsky GS, van Golen KL. The current understanding of the molecular determinants of inflammatory breast cancer metastasis. Clinical & Experimental Metastasis. 22: 615-20. PMID 16642401 DOI: 10.1007/s10585-006-9000-7 |
0.609 |
|
2005 |
Zhang X, Lin M, van Golen KL, Yoshioka K, Itoh K, Yee D. Multiple signaling pathways are activated during insulin-like growth factor-I (IGF-I) stimulated breast cancer cell migration. Breast Cancer Research and Treatment. 93: 159-68. PMID 16187236 DOI: 10.1007/S10549-005-4626-8 |
0.388 |
|
2005 |
Kleer CG, Griffith KA, Sabel MS, Gallagher G, van Golen KL, Wu ZF, Merajver SD. RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast. Breast Cancer Research and Treatment. 93: 101-10. PMID 16187229 DOI: 10.1007/S10549-005-4170-6 |
0.603 |
|
2005 |
Arumugam T, Simeone DM, Van Golen K, Logsdon CD. S100P promotes pancreatic cancer growth, survival, and invasion. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 5356-64. PMID 16061848 DOI: 10.1158/1078-0432.CCR-05-0092 |
0.353 |
|
2005 |
Lin M, DiVito MM, Merajver SD, Boyanapalli M, van Golen KL. Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1. Molecular Cancer. 4: 21. PMID 15969750 DOI: 10.1186/1476-4598-4-21 |
0.439 |
|
2004 |
Lin M, van Golen KL. Rho-regulatory proteins in breast cancer cell motility and invasion. Breast Cancer Research and Treatment. 84: 49-60. PMID 14999154 DOI: 10.1023/B:BREA.0000018424.43445.f3 |
0.589 |
|
2003 |
van Golen KL. Inflammatory breast cancer: relationship between growth factor signaling and motility in aggressive cancers. Breast Cancer Research : Bcr. 5: 174-9. PMID 12793901 DOI: 10.1186/bcr598 |
0.5 |
|
2002 |
van Golen KL, Bao L, DiVito MM, Wu Z, Prendergast GC, Merajver SD. Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor. Molecular Cancer Therapeutics. 1: 575-83. PMID 12479217 |
0.552 |
|
2002 |
Pan Q, Kleer CG, van Golen KL, Irani J, Bottema KM, Bias C, De Carvalho M, Mesri EA, Robins DM, Dick RD, Brewer GJ, Merajver SD. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Research. 62: 4854-9. PMID 12208730 |
0.405 |
|
2002 |
van Golen KL, Bao L, Brewer GJ, Pienta KJ, Kamradt JM, Livant DL, Merajver SD. Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma. Neoplasia (New York, N.Y.). 4: 373-9. PMID 12192595 DOI: 10.1038/Sj.Neo.7900258 |
0.309 |
|
2002 |
Kleer CG, Tseng MD, Gutsch DE, Rochford RA, Wu Z, Joynt LK, Helvie MA, Chang T, Van Golen KL, Merajver SD. Detection of Epstein-Barr virus in rapidly growing fibroadenomas of the breast in immunosuppressed hosts. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 15: 759-64. PMID 12118114 DOI: 10.1038/Modpathol.3880602 |
0.443 |
|
2002 |
van Golen KL, Bao LW, Pan Q, Miller FR, Wu ZF, Merajver SD. Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer. Clinical & Experimental Metastasis. 19: 301-11. PMID 12090470 DOI: 10.1023/A:1015518114931 |
0.547 |
|
2002 |
Kleer CG, Zhang Y, Pan Q, van Golen KL, Wu ZF, Livant D, Merajver SD. WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Oncogene. 21: 3172-80. PMID 12082632 DOI: 10.1038/Sj.Onc.1205462 |
0.517 |
|
2002 |
Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. The American Journal of Pathology. 160: 579-84. PMID 11839578 DOI: 10.1016/S0002-9440(10)64877-8 |
0.533 |
|
2000 |
Kleer CG, van Golen KL, Merajver SD. Molecular biology of breast cancer metastasis. Inflammatory breast cancer: Clinical syndrome and molecular determinants Breast Cancer Research. 2: 423-429. PMID 11250736 DOI: 10.1186/Bcr89 |
0.594 |
|
2000 |
Van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD. RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells Neoplasia. 2: 418-425. PMID 11191108 DOI: 10.1038/Sj.Neo.7900115 |
0.525 |
|
Show low-probability matches. |